Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 3, 2002, Pages 784-795

  Chow, Sin Ming ^a   Law, Stephen C K ^a   Mendenhall, William M ^b   Au, Siu Kie ^a   Chan, Paddy T M ^a   Leung, To Wai ^c   Tong, Chi Chung ^a   Wong, Irene S M ^a   Lau, Wai Hon ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Iodine radioisotopes; Papillary carcinoma; Radiotherapy; Surgery; Thyroid neoplasms

Indexed keywords

DIAGNOSIS; DISEASES; MULTIVARIABLE SYSTEMS; ONCOLOGY;

PAPILLARY THYROID CARCINOMA;

RADIOTHERAPY;

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RADIOTHERAPY; REGISTRATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; STATISTICAL ANALYSIS; SURVIVAL RATE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT INDICATION; TREATMENT OUTCOME;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, PAPILLARY; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 0036498574     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02686-4     Document Type: Article

References (57)

1. Intermediate-risk group for differentiated carcinoma of thyroid
2. Papillary thyroid carcinoma
3. An expanded view of risk-group definition in differentiated thyroid carcinoma
4. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
5. Classification of papillary cancer of the thyroid based on prognosis
6. Prospective multicenter study of thyroid carcinoma treatment: Initial analysis of staging and outcome
7. Natural history, treatment, and course of papillary thyroid carcinoma
8. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example
9. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective
10. Regression models and life tables
11. Papillary thyroid carcinoma: A multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system
12. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients
13. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-1991
14. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
15. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma
16. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups
17. Survival of differentiated thyroid carcinoma studied in 500 patients
18. Thyroid cancer: A multivariate analysis on influence of treatment on long-term survival
19. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
20. The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients
21. Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
22. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma
23. Extent of surgery for intermediate-risk-well-differentiated thyroid cancer
24. Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?
25. Post-operative complications after completion thyroidectomy for differentiated thyroid cancer
26. Second operations for "completion" of thyroidectomy in treatment of differentiated thyroid cancer
27. Necessity and safety of completion thyroidectomy for differentiated thyroid carcinoma
28. Surgical therapy for thyroid carcinoma: A review of 1249 solitary thyroid nodules
29. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: A matched-pair analysis
30. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma
31. Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients
32. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma
33. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment
34. Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables
35. Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma - A critique
36. Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma
37. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer
38. Radioiodine ablation of residual tissue in thyroid cancer: Relationship between administered activity, neck uptake and outcome
39. Radioiodine treatment for differentiated thyroid cancer
40. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy
41. Sialadenitis following I-131 therapy for thyroid carcinoma: Concise communication
42. Local reactions to radioiodine in the treatment of thyroid cancer
43. The long-term hazards of the treatment of thyroid cancer with radioiodine
44. Leukemia after a small dose of radioiodine for metastatic thyroid cancer
45. Cancer incidence following treatment of hyperthyroidism
46. Leukaemias and cancers following iodine-131 administration for thyroid cancer
47. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas
48. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma
49. Differentiated thyroid cancer long-term impact of initial therapy
50. Prophylactic external irradiation in differentiated thyroid cancer: A retrospective study over a 30-year observation period
51. Value of postoperative radiotherapy for thyroid cancer
52. Results of external beam radiotherapy in differentiated thyroid carcinoma: A retrospective study from the Royal Marsden Hospital
53. External radiotherapy in thyroid cancers
54. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)